Correlation Between Genmab AS and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Genmab AS and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Apellis Pharmaceuticals.
Diversification Opportunities for Genmab AS and Apellis Pharmaceuticals
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Genmab and Apellis is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Genmab AS i.e., Genmab AS and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Genmab AS and Apellis Pharmaceuticals
Given the investment horizon of 90 days Genmab AS is expected to generate 0.62 times more return on investment than Apellis Pharmaceuticals. However, Genmab AS is 1.6 times less risky than Apellis Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 2,087 in Genmab AS on November 1, 2024 and sell it today you would lose (106.00) from holding Genmab AS or give up 5.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.0% |
| Values | Daily Returns |
Genmab AS vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Genmab AS |
| Apellis Pharmaceuticals |
Genmab AS and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genmab AS and Apellis Pharmaceuticals
The main advantage of trading using opposite Genmab AS and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Genmab AS vs. Ascendis Pharma AS | Genmab AS vs. Apellis Pharmaceuticals | Genmab AS vs. Akero Therapeutics | Genmab AS vs. Blueprint Medicines Corp |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |